Tranche Update on AFC-HD AMS Life Science Co., Ltd.'s Equity Buyback Plan announced on October 27, 2021.
December 22, 2021 at 01:30 am EST
Share
From October 27, 2021 to December 21, 2021, the company has repurchased 300,000 shares, representing 2.11% for ¥289.44 million. With this, the company has completed the repurchase of 300,000 shares, representing 2.11% for ¥289.44 million under the buyback announced on October 27, 2021.
AFC-HD AMS Life Science Co Ltd is a Japan-based company mainly engaged in the development of the healthcare business and the pharmaceutical business. The Company is engaged in the research and development, product design, manufacture and sale of health foods and cosmetics, manufacture and sale of Chinese medicine medicines, general medicines, generic medicines, healthcare products, the sale of natural foods, as well as planning of health information programs. The Company operates in two business segments. The Healthcare segment is engaged in the manufacture and sale of health foods and cosmetics, as well as the provision of original equipment manufacturers (OEM). The Pharmaceutical segment is engaged in the manufacture and sale of ethical drugs and over-the-counter drugs, as well as the sale of generic drugs. The Company is also engaged in the management of restaurants through subsidiary.
AFC-HD AMS LIFE SCIENCE CO., LTD. 
